Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety, tolerability, and immunogenicity of an alternative manufacturing process for MMRV vaccine (AMP) with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• MMRV vaccine (AMP)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED | Results posted: 2014-07-02